Literature DB >> 22161903

Quality measurement as a prerequisite for improving hypertension control in an academic medical center.

Fani E Syrrokosta1, Konstantinos M Lampropoulos, Ioannis Papargyriou, Dimitrios Papadogiannis.   

Abstract

BACKGROUND: Quality of care provided by the outpatient hypertension unit of a general hospital was measured using quality indicators (QIs) derived from guidelines. HYPOTHESIS: Measuring provided quality of care is an important step for improving it.
METHODS: We enrolled 1206 patients with hypertension, 626 men and 580 women, with a mean age of 55.33 ± 12.08 years. Median follow-up was 47 months (minimum: 6 months, maximum: 349 months, interquartile range). We calculated the percentage of patients who achieved the targets of controlling blood pressure (BP), total cholesterol, low- and high-density lipoprotein cholesterol, triglycerides, glucose, uric acid, potassium, sodium, creatinine clearance, Sokolow-Lyon index, and left ventricle hypertrophy in echo between the first and the last visit. Patient satisfaction and the incidence of coronary artery disease (CAD), myocardial infarction (MI), and stroke were evaluated as outcome indicators.
RESULTS: The BP was controlled in 40% of patients at the end of the study, compared with 11% at the first visit. We did not manage to achieve significant improvement for other QIs. A wide range of hypertensive patients and lack of a quality improvement program are the main reasons for low control rate. During follow-up, we obtained the increased incidence of cardiovascular events by outcome indicators such as CAD, MI, and stroke.
CONCLUSIONS: Quality measurement shows us that the quality of provided care needs further improvement. Although we succeeded in controlling BP in 40% of patients, we did not manage to improve the other QIs. Modifying our structure and process components, we are working on improving outcome by achieving better control of QIs.
© 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 22161903      PMCID: PMC6652557          DOI: 10.1002/clc.21000

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  25 in total

1.  Evaluating hypertension control in a managed care setting.

Authors:  M Alexander; I Tekawa; E Hunkeler; B Fireman; R Rowell; J V Selby; B M Massie; W Cooper
Journal:  Arch Intern Med       Date:  1999 Dec 13-27

2.  Measuring and improving quality of care: a report from the American Heart Association/American College of Cardiology First Scientific Forum on Assessment of Healthcare Quality in Cardiovascular Disease and Stroke.

Authors: 
Journal:  Circulation       Date:  2000-03-28       Impact factor: 29.690

3.  The public release of performance data: what do we expect to gain? A review of the evidence.

Authors:  M N Marshall; P G Shekelle; S Leatherman; R H Brook
Journal:  JAMA       Date:  2000-04-12       Impact factor: 56.272

4.  Self-reported hypertension treatment practices among primary care physicians: blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine.

Authors:  D J Hyman; V N Pavlik
Journal:  Arch Intern Med       Date:  2000 Aug 14-28

Review 5.  Clinical inertia.

Authors:  L S Phillips; W T Branch; C B Cook; J P Doyle; I M El-Kebbi; D L Gallina; C D Miller; D C Ziemer; C S Barnes
Journal:  Ann Intern Med       Date:  2001-11-06       Impact factor: 25.391

6.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

7.  Predictors of uncontrolled hypertension in ambulatory patients.

Authors:  E L Knight; R L Bohn; P S Wang; R J Glynn; H Mogun; J Avorn
Journal:  Hypertension       Date:  2001-10       Impact factor: 10.190

8.  Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration.

Authors:  B Neal; S MacMahon; N Chapman
Journal:  Lancet       Date:  2000-12-09       Impact factor: 79.321

9.  Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study.

Authors:  Ramachandran S Vasan; Alexa Beiser; Sudha Seshadri; Martin G Larson; William B Kannel; Ralph B D'Agostino; Daniel Levy
Journal:  JAMA       Date:  2002-02-27       Impact factor: 56.272

10.  Physician-related barriers to the effective management of uncontrolled hypertension.

Authors:  Susan A Oliveria; Pablo Lapuerta; Bruce D McCarthy; Gilbert J L'Italien; Dan R Berlowitz; Steven M Asch
Journal:  Arch Intern Med       Date:  2002-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.